Macclesfield, United Kingdom

Rodger M McMillan

This inventor holds 1 USPTO granted patent. Top assignees: Ici Pharma, Imperial Chemical Industries Limited. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rodger M McMillan. Retrieved from https://idiyas.com/inventor/rodger-m-mcmillan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rodger M McMillan: Innovator in Pharmaceutical Compositions

Introduction

Rodger M McMillan is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on therapeutic preparations.

Latest Patents

Rodger M McMillan holds a patent for "Therapeutic preparations containing indazole derivatives." This invention focuses on pharmaceutical compositions that include a 1,2-dihydro-3H-indazol-3-one derivative. The patent outlines various chemical structures and their potential applications in treating allergic and inflammatory diseases. The invention also introduces novel 1,2-dihydro-3H-indazol-3-ones, processes for their production, and their use in the manufacture of medicaments.

Career Highlights

Throughout his career, Rodger has worked with prominent companies such as ICI Pharma and Imperial Chemical Industries Limited. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Rodger has collaborated with notable professionals in the field, including Pierre A Bruneau and Frank Carey. These partnerships have likely enhanced his research and development efforts.

Conclusion

Rodger M McMillan's contributions to pharmaceutical compositions demonstrate his innovative spirit and commitment to advancing medical treatments. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…